Lone Peak: The Pediatric DSO Backed by BlackRock

Most dental roll-ups chase commercially insured adults in affluent suburbs. Lone Peak Dental Group built a national platform doing close to the opposite: pediatric specialty care for Medicaid-eligible children, often in communities where the nearest children's dentist can be an hour's drive away. That contrarian focus is what has drawn impact-oriented institutional capital to a company that began with three Denver offices and two pediatric dentists, and it is the lens through which any operator or investor should read its footprint, its financing, and its growth runway.

Overview

Lone Peak Dental Group is a Denver-area pediatric specialty dental support organization (DSO) focused almost entirely on dentistry and orthodontics for children and adolescents. Founded in 2003 by two pediatric dentists with three Denver locations, it has grown into one of the larger pediatric-focused platforms in the country, with a company-reported network of more than 75 offices across 14 states.¹ The organization is run from a central "Smile Center" in the Denver metro (Englewood, Colorado), where its executive team and shared-services functions sit.¹

What sets Lone Peak apart from a conventional corporate DSO is how it describes its own structure. Rather than a top-down chain, the company positions itself as a "Dental Partnership Organization," or DPO, built on an owner-doctor model that gives partner dentists equity participation at the local practice level while the central platform handles billing, compliance, marketing, and other back-office functions.¹ That partnership emphasis puts it in the same structural conversation as physician- and dentist-ownership models like MB2 Dental, even as its clinical focus and payer mix look much more like pediatric-Medicaid peers such as Benevis and Hero Practice Services.

The clinical and payer focus is the throughline. Lone Peak's practices primarily serve Medicaid-eligible children and underserved communities, a deliberate choice given that more than 40% of U.S. children are covered by Medicaid or CHIP.² The company reports that it employs over 150 dentists and that roughly 81% of its platform staff are bilingual, reflecting the diverse, frequently lower-income communities its clinics are designed to reach.²

A quick disambiguation note for anyone researching the name: several unrelated dental practices use "Lone Peak" as a local descriptor — for example, a Burg Children's Dentistry location in Sandy, Utah, and independent offices elsewhere. Those are not part of the Denver-headquartered DSO profiled here, which operates through its own set of regional brands rather than a single "Lone Peak" retail name.¹

Company Snapshot

• Headquarters: Englewood, Colorado (Denver metro), operating as the "Smile Center"¹
• Founded: 2003, by two pediatric dentists, starting with three Denver locations¹
• Structure: Pediatric specialty DSO; self-described "Dental Partnership Organization" (DPO) with an owner-doctor equity model¹
• Clinical focus: Pediatric dentistry, orthodontics, and related specialty services for children³
• Footprint (company-reported): More than 75 offices across 14 states¹
• Patients served: More than 680,000 children annually (company-reported)³
• Workforce: 150+ dentists; approximately 81% bilingual platform staff²
• Leadership: Ray Caruso (President and CEO), Christina Carlson (CFO), Susanne Reams (CPO), Mandy Gast (CDO), Eduardo Laventman (COO)¹
• Notable backers: BlackRock Impact Opportunities Fund and Memorial Hermann Health System (equity); Brightwood Capital, LBC Credit Partners, and o15 Capital Partners (debt/financing)²

Footprint Analysis

Lone Peak's location count is best read as a moving target, because the figure has climbed quickly and different sources capture different moments. At the time of its January 2024 equity investment, the company described itself as supporting 69 pediatric dental clinics across 13 states.² By late 2025 and into 2026, company press releases and industry coverage consistently described more than 75 offices across 14 states, with one industry profile citing 73 affiliated offices at a slightly earlier snapshot.¹ The reasonable read is a network in the mid-to-high 70s of offices across roughly 14 states, growing through a mix of acquisitions and new openings, with the exact count drifting month to month.

It is also worth distinguishing offices from practices and brands. Lone Peak operates through a portfolio of locally branded practices rather than a single national marquee — names like Adventure Dental & Orthodontics, Harbor Kids Dental, Lollipop Pediatric Dentistry & Orthodontics, AZ Family & Kid's Dental, Ohio Kids Dental, and acquired practices such as Eastpoint Pediatric Dental Associates in Maryland.¹ Headcounts of "offices," "practices," and "brands" are therefore not interchangeable, and any precise number should be treated as company-reported and approximate.

Geographically, the company's stated footprint spans Alabama, Arizona, Colorado, Georgia, Idaho, Nebraska, Nevada, Maryland, Ohio, South Carolina, Tennessee, Texas, Virginia, and Washington.¹ That distribution leans toward the West (Arizona, Colorado, Idaho, Nevada, Washington) and the South and Mid-Atlantic (Alabama, Georgia, South Carolina, Tennessee, Texas, Virginia, Maryland) — markets that combine large child populations with meaningful Medicaid and CHIP enrollment. Lone Peak appears to favor density within states: South Carolina reached ten pediatric practices following a late-2025 acquisition,¹ and the greater Phoenix/Mesa area reached five practices after an Arizona deal.³ Clustering of this kind is a recognizable DSO strategy, supporting shared staffing, marketing, and management leverage within a region rather than scattering isolated clinics.

Growth History

Lone Peak's arc runs from a small Denver group practice to an institutionally backed national platform over roughly two decades. The early years centered on building pediatric practices in the Denver area; the more consequential phase for investors began when outside capital arrived to fund a dual strategy of de novo openings and affiliations with established pediatric practices.¹

The pivotal event was the January 2024 strategic investment from the BlackRock Impact Opportunities Fund, with Memorial Hermann Health System investing alongside it as an equity co-investor and Brightwood Capital and LBC Credit Partners providing the financing.² Terms of that transaction were not disclosed, so the precise ownership split among the founders, management, BlackRock, and Memorial Hermann cannot be confirmed; what can be said is that the company became an institutionally backed, privately held platform rather than a founder-owned group, and that BlackRock's impact mandate aligned with Lone Peak's Medicaid-focused mission.²

Financing continued after the equity round. According to industry coverage, o15 Capital Partners made an original investment in October 2024 and then provided an additional, company-reported $15 million in mezzanine debt disclosed in mid-2026 to fund "the next phase of expansion," including strategic acquisitions and specialty offerings.³ Mezzanine debt typically sits between senior loans and equity, which lets a company fund deals without immediately diluting existing owners — a sensible tool for a platform running an active acquisition pipeline.

That pipeline has been visible in named deals. Lone Peak acquired AZ Family & Kid's Dental in Phoenix, reaching five practices in the Phoenix/Mesa region,³ and in November 2025 acquired the long-standing North Augusta, South Carolina practice of Dr. Deborah Ashcraft, bringing the company's South Carolina presence to ten pediatric practices.¹ The leadership team has been built out in parallel, including the January 2025 addition of Mandy Gast as Chief Development Officer to lead acquisitions and de novo growth.¹ Financial terms of the individual practice acquisitions have generally not been disclosed.

Competitive Landscape

Lone Peak competes in a narrower lane than the giants of dental consolidation. The largest DSOs — platforms in the mold of Heartland Dental — are built primarily around general dentistry for commercially insured adults, operating at a scale measured in the hundreds or thousands of locations. Lone Peak's relevant peer set is the smaller group of pediatric- and Medicaid-oriented organizations, where the competitive dynamics, reimbursement realities, and regulatory scrutiny are meaningfully different.

Its closest comparables are pediatric-Medicaid specialists such as Benevis (the support organization historically associated with Kool Smiles) and Hero Practice Services, both of which similarly concentrate on children's dentistry, orthodontics, and public-insurance populations. Against those peers, Lone Peak's differentiation is its owner-doctor partnership framing, which it uses to recruit and retain pediatric dentists who want clinical autonomy and equity rather than a salaried role — a positioning that overlaps conceptually with partnership-model platforms in general dentistry even though the clinical focus differs.

The pediatric-Medicaid segment carries a distinct risk-and-reward profile that any investor should weigh. On the reward side, demand is durable, the patient population is large and underserved, and impact-aligned capital is available. On the risk side, the model is heavily exposed to state Medicaid reimbursement rates and policy, demands disciplined billing and compliance, and has historically attracted regulatory attention across the sector around utilization in pediatric care.⁴ Lone Peak's emphasis on centralized compliance and a five-year partner-doctor commitment can be read as deliberate responses to exactly those pressures.

Market Position

Lone Peak occupies a defensible niche: one of the larger pure-play pediatric specialty platforms in a fragmented segment that the mega-DSOs largely do not target. Its combination of clinical specialization, a Medicaid-centric payer mix, bilingual staffing, and an owner-doctor partnership model is coherent and hard to replicate quickly, and it has been validated by a capital structure that pairs impact-oriented equity with health-system and private-credit financing.²

For operators, the company's pitch is a credible one — equity participation, mentorship for early-career pediatric dentists, and back-office support tuned to the specific complexities of Medicaid pediatric billing. For investors, the platform reads as a mission-aligned, acquisitive consolidator with an identified runway in a segment where access gaps remain wide. The principal sensitivities are the ones inherent to the niche: reimbursement dependence, the operational discipline required to run Medicaid-heavy clinics profitably, and the sector-wide scrutiny that accompanies pediatric care under public insurance. Whether the platform's many disclosed and undisclosed financing layers ultimately translate into durable returns will depend on execution against those constraints — but the strategic position itself is clear and distinctive.

TMR Take: Lone Peak is a rare thing in dental consolidation — a sizable platform that deliberately serves Medicaid-eligible children rather than routing around them. For operators, the owner-doctor DPO structure is a genuine recruiting advantage in a specialty where autonomy matters and de novo risk is real. For investors, the appeal is a differentiated, impact-aligned consolidator with backing from BlackRock's Impact Opportunities Fund, Memorial Hermann, and private-credit lenders, and an active acquisition pipeline; the watch-items are reimbursement exposure, compliance intensity, and the fact that ownership splits and deal terms remain undisclosed. Read every footprint figure as company-reported and approximate — the network is real and growing, but "offices," "practices," and "brands" are not the same count, and the precise number moves with each deal.

Sources

1. Lone Peak Dental Group — company website, About page, and acquisition press releases.

2. BlackRock Impact Opportunities Fund investment — Lone Peak Dental Group company disclosures.

3. Group Dentistry Now — DSO industry coverage and o15 Capital Partners investment disclosures.

4. Pediatric DSO competitive context — TMR research.